Attention:
Card image cap

North Dakota (ND) Litigation CLE Course Catalog

Explore our entire library of CLE courses. Search the whole catalog or filter courses by state, practice area, provider, credit type, and format

Sort by

All CLE Courses For North Dakota (ND) Litigation

Card image cap
62 minutes
cc
When an Investigation Hits: Strategies for Effective and Rapid Resolution When Your Team is Remote
In this CLE-accredited session, hear from leading legal experts on how they have short-circuited often expensive and time-consuming investigations efforts to find the evidence that will tell the story. They will share their experiences on collecting data from remote employees, ephemeral data preservation obligations and effective instant messaging, social media and BYOD policies, project management techniques, and use of targeted analytics approaches to assess potential evidence.

Legalweek

$65

Add to Cart
Card image cap
59 minutes
cc
Navigating Regulatory Compliance Through Effective Data Protection and Governance Strategy
All it takes is one employee clicking on the wrong link in an email, and the hundreds of thousands of dollars you spend on your security infrastructure are useless. So to sit back and rely on your IT department with the expectation that nothing will ever go wrong is a risky proposition. Issues related to data privacy and cybersecurity are not limited to large organizations. In fact, depending on what reports you read, anywhere from 40% to 60% of cyber-attacks specifically target small to medium-sized businesses, and upwards of 70% of small businesses have experienced some form of cyberattack in the last year. The smaller the business, the fewer the resources it will typically have to spend on cybersecurity. If you think a good cybersecurity plan and infrastructure is too expensive, wait until you find out how much it costs not to have one.

Legalweek

$65

Add to Cart
Card image cap
73 minutes
cc
Intercreditor Disputes
This panel will examine creditors vs. creditors in liability-management transactions (Boardriders, Serta, Travelport, Trimark), collective actions and credit bidding (Speedcast, Alta Masa, Empire Generating, Allied), strict foreclosure in light of TIA 316(b) (CNH Diversified Opportunities v. Cleveland Unlimited), de facto claim-subordination (La Paloma), rights preserved for junior creditors under an intercreditor agreement (do the exceptions swallow the rule (Claires, Momentive)?), and practical considerations such as coordination agreements, unitranche facilities and CLOs in restructurings.

American Bankruptcy Institute

$95

Add to Cart
Card image cap
72 minutes
cc
Pandemic Pandemonium: Litigating in the Time of COVID-19
This panel also will cover topics ranging from access to courts, to the increased use of inherent judicial power, to virtual trials, to valuation and compromise in uncertain (unprecedented) times, to recent developments in avoidance actions.

American Bankruptcy Institute

$75

Add to Cart
Card image cap
58 minutes
cc
Litigating Director and Officer Claims in Bankruptcy
A frequent element of bankruptcy cases is the assertion of claims against the directors and officers of the debtor, particularly when the debtor has a significant D&O insurance policy. This panel will explore the use of fiduciary-duty litigation in bankruptcy by dissecting the anatomy of a D&O lawsuit, including the types of claims asserted and their possible defenses. The panelists will also discuss how to analyze D&O insurance policies, and such key issues as whether the proceeds of D&O policies are considered property of the estate. Finally, the panelists will highlight best practices for debtors’ counsel faced with such claims, and show how to navigate potential ethical issues.

American Bankruptcy Institute

$75

Add to Cart
Card image cap
66 minutes
cc
Litigating Common Causes of Action in Bankruptcy
Covering a wide array of bankruptcy litigation matters, this session will focus on issues relating to stay relief, discharge litigation, and post-discharge injunction matters. Evidentiary considerations and standards for relief will be highlighted, along with case law developments and practice tips from the experienced panelists.

American Bankruptcy Institute

$75

Add to Cart
Card image cap
171 minutes
cc
Subchapter V and Virtual Court: A Tale of Two Frontiers
The Small Business Reorganization Act of 2019 went into effect a mere few weeks before a worldwide pandemic unfolded, setting into motion unforeseen challenges and learning curves for the entire bankruptcy court system. This session consists of two mock presentations that will demonstrate the application of technology in the pre-trial practice and trial presentation of a subchapter V virtual trial. Included in these presentations will be virtual depositions and document preparation and organization, as well as the nontechnical challenges these cases can face, such as feasibility, projected-income issues, best practices assuming a nonconsensual plan, and cramdown. During the mock presentations, a team of technology experts will interject real-time, practical tips on the risks, benefits and potential ethical pitfalls of technology use in virtual trials, and much more.

American Bankruptcy Institute

$205

Add to Cart
Card image cap
73 minutes
cc
Witness Preparation: A Roundtable Discussion
Witness testimony at trial and in depositions is critical to winning. This panel of restructuring/insolvency litigators and expert witnesses will discuss how you prepare your fact and expert witnesses, including how to respond to direct examination, how to respond to personal attacks and lies, how to deal with an aggressive lawyer, how to prep a fact witness versus an expert witness, and how an expert witness should prep an attorney.

American Bankruptcy Institute

$95

Add to Cart
Card image cap
-1
74 minutes
cc
Anatomy of a Pharmaceutical Bankruptcy Case
This panel will present a primer on the U.S. pharmaceutical industry, focusing on the typical capital structures of pharmaceutical/development companies versus in-pipeline companies. The panelists will examine the factors leading to the recent surge in pharmaceutical bankruptcy cases and their outcomes/resolutions, as well as ? 363 sales of pharmaceutical companies’ assets and restructurings. Opiate bankruptcy cases such as Purdue and Mallinckrodt will be highlighted, as will ancillary issues that arise in pharmaceutical bankruptcy cases, such as product recalls, regulatory issues (such as with the FDA) and IP licensing issues.

American Bankruptcy Institute

$95

Add to Cart
    s